Human Brain theVirus-Induced Demyelinating Disease of Leukoencephalopathy , the JC Pathogenesis of Progressive Multifocal

[1]  J. Bilbao,et al.  JC virus granular neuronopathy and rhombencephalic progressive multifocal leukoencephalopathy: Case report and review of the literature , 2012, Neuropathology : official journal of the Japanese Society of Neuropathology.

[2]  X. Montalban,et al.  Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab , 2012, Multiple sclerosis.

[3]  I. Koralnik,et al.  Frequent Infection of Cortical Neurons by JC Virus in Patients With Progressive Multifocal Leukoencephalopathy , 2012, Journal of neuropathology and experimental neurology.

[4]  V. Sondak,et al.  Age-Specific Seroprevalence of Merkel Cell Polyomavirus, BK Virus, and JC Virus , 2011, Clinical and Vaccine Immunology.

[5]  Ari Helenius,et al.  Lipid-mediated endocytosis. , 2011, Cold Spring Harbor perspectives in biology.

[6]  J. Carulli,et al.  Sequencing and Analysis of JC Virus DNA From Natalizumab-Treated PML Patients , 2011, The Journal of infectious diseases.

[7]  J. Carulli,et al.  Progressive multifocal leukoencephalopathy (PML) development is associated with mutations in JC virus capsid protein VP1 that change its receptor specificity. , 2011, The Journal of infectious diseases.

[8]  G. Lucchini,et al.  Polyomavirus JC-targeted T-cell therapy for progressive multiple leukoencephalopathy in a hematopoietic cell transplantation recipient , 2011, Bone Marrow Transplantation.

[9]  D. Costagliola,et al.  Improved Survival of HIV-1-Infected Patients with Progressive Multifocal Leukoencephalopathy Receiving Early 5-Drug Combination Antiretroviral Therapy , 2011, PloS one.

[10]  S. Bowden,et al.  Immunosuppression increases latent infection of brain by JC polyomavirus , 2011, Pathology.

[11]  A. Nath,et al.  Immune reconstitution inflammatory syndrome and the central nervous system. , 2011, Current opinion in neurology.

[12]  D. Adams,et al.  JC virus granule cell neuronopathy and hyper-IgE in HIV disease , 2011, Neurology.

[13]  S. Cucchiara,et al.  Polyomavirus JC reactivation and noncoding control region sequence analysis in pediatric Crohn's disease patients treated with infliximab , 2011, Journal of NeuroVirology.

[14]  Billy Tsai,et al.  A Large and Intact Viral Particle Penetrates the Endoplasmic Reticulum Membrane to Reach the Cytosol , 2011, PLoS pathogens.

[15]  M. Zaffaroni,et al.  Serological evidence of vertical transmission of JC and BK polyomaviruses in humans. , 2011, The Journal of general virology.

[16]  D. Bengel,et al.  Functional Energetics of CD4+-Cellular Immunity in Monoclonal Antibody-Associated Progressive Multifocal Leukoencephalopathy in Autoimmune Disorders , 2011, PloS one.

[17]  M. Singer,et al.  SV40 host-substituted variants: a new look at the monkey DNA inserts and recombinant junctions. , 2011, Virology.

[18]  R. Friedman.  News from the AAN Annual Meeting: Malaria Drug Fails to Fulfill Promise in PML , 2011 .

[19]  K. Khalili,et al.  Role for tumor necrosis factor-alpha in JC virus reactivation and progressive multifocal leukoencephalopathy , 2011, Journal of Neuroimmunology.

[20]  C. Delaugerre,et al.  JC Virus Variant Associated with Cerebellar Atrophy in a Patient with AIDS , 2011, Journal of Clinical Microbiology.

[21]  E. Major,et al.  CMX001 (1-O-Hexadecyloxypropyl-Cidofovir) Inhibits Polyomavirus JC Replication in Human Brain Progenitor-Derived Astrocytes , 2011, Antimicrobial Agents and Chemotherapy.

[22]  M. Jiang,et al.  Functional reorganization of promyelocytic leukemia nuclear bodies during BK virus infection. , 2011, mBio.

[23]  A. Helenius,et al.  Role of Endosomes in Simian Virus 40 Entry and Infection , 2011, Journal of Virology.

[24]  David W. Holman,et al.  The blood-brain barrier, chemokines and multiple sclerosis. , 2011, Biochimica et biophysica acta.

[25]  K. Khalili,et al.  Regulation of Human Neurotropic JC Virus Replication by Alternative Splicing Factor SF2/ASF in Glial Cells , 2011, PloS one.

[26]  M. H. Lehmann,et al.  HIV-1 Nef increases astrocyte sensitivity towards exogenous hydrogen peroxide , 2011, Virology Journal.

[27]  Billy Tsai,et al.  A PDI Family Network Acts Distinctly and Coordinately with ERp29 To Facilitate Polyomavirus Infection , 2010, Journal of Virology.

[28]  E. Major,et al.  Transcription factor Spi-B binds unique sequences present in the tandem repeat promoter/enhancer of JC virus and supports viral activity , 2010, The Journal of general virology.

[29]  S. Sugiura,et al.  Efficient propagation of progressive multifocal leukoencephalopathy‐type JC virus in COS‐7‐derived cell lines stably expressing Tat protein of human immunodeficiency virus type 1 , 2010, Microbiology and immunology.

[30]  D. Clifford,et al.  Progressive multifocal leukoencephalopathy and other forms of JC virus disease , 2010, Nature Reviews Neurology.

[31]  T. Bouldin,et al.  A case of progressive multifocal leukoencephalopathy in a patient treated with infliximab. , 2010, Arthritis and rheumatism.

[32]  T. Werner,et al.  Control of HIV replication in astrocytes by a family of highly conserved host proteins with a common Rev-interacting domain (Risp) , 2010, AIDS.

[33]  E. Major,et al.  Hexadecyloxypropyl-Cidofovir (CMX001) Suppresses JC Virus Replication in Human Fetal Brain SVG Cell Cultures , 2010, Antimicrobial Agents and Chemotherapy.

[34]  E. Major,et al.  JC virus persistence following progressive multifocal leukoencephalopathy in multiple sclerosis patients treated with natalizumab , 2010, Annals of neurology.

[35]  K. Simon,et al.  Anti‐JC virus antibodies: Implications for PML Risk Stratification , 2010, Annals of neurology.

[36]  A. Goonetilleke,et al.  Evaluating sewage-associated JCV and BKV polyomaviruses for sourcing human fecal pollution in a coastal river in Southeast Queensland, Australia. , 2010, Journal of environmental quality.

[37]  D. Clifford,et al.  Clinical outcome of long-term survivors of progressive multifocal leukoencephalopathy , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[38]  E. Major,et al.  Rearranged JC Virus Noncoding Control Regions Found in Progressive Multifocal Leukoencephalopathy Patient Samples Increase Virus Early Gene Expression and Replication Rate , 2010, Journal of Virology.

[39]  Mengding Qian,et al.  Lipids and Proteins Act in Opposing Manners To Regulate Polyomavirus Infection , 2010, Journal of Virology.

[40]  M. Maginnis,et al.  Role of N-Linked Glycosylation of the 5-HT2A Receptor in JC Virus Infection , 2010, Journal of Virology.

[41]  V. Nerurkar,et al.  Human polyomavirus JC (JCV) infection of human B lymphocytes: a possible mechanism for JCV transmigration across the blood-brain barrier. , 2010, The Journal of infectious diseases.

[42]  L. Ngo,et al.  JC Virus Latency in the Brain and Extraneural Organs of Patients with and without Progressive Multifocal Leukoencephalopathy , 2010, Journal of Virology.

[43]  R. McLachlan,et al.  Mefloquine in the treatment of progressive multifocal leukoencephalopathy , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[44]  M. Calabrese,et al.  No evidence of JC virus reactivation in natalizumab treated multiple sclerosis patients: an 18 month follow-up study , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[45]  Y. Shishido‐Hara.  Progressive multifocal leukoencephalopathy and promyelocytic leukemia nuclear bodies: a review of clinical, neuropathological, and virological aspects of JC virus-induced demyelinating disease , 2010, Acta Neuropathologica.

[46]  R. Frisque,et al.  JC Virus Small t Antigen Binds Phosphatase PP2A and Rb Family Proteins and Is Required for Efficient Viral DNA Replication Activity , 2010, PloS one.

[47]  E. Major,et al.  Molecular Regulation of JC Virus Tropism: Insights into Potential Therapeutic Targets for Progressive Multifocal Leukoencephalopathy , 2010, Journal of Neuroimmune Pharmacology.

[48]  Y. Niv,et al.  Patients With Sporadic Colorectal Cancer or Advanced Adenomatous Polyp Have Elevated Anti-JC Virus Antibody Titer in Comparison With Healthy Controls: A Cross-sectional Study , 2010, Journal of clinical gastroenterology.

[49]  I. Koralnik,et al.  Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis , 2010, The Lancet Neurology.

[50]  J. Bourhis,et al.  JC human polyomavirus is associated to chromosomal instability in peripheral blood lymphocytes of Hodgkin's lymphoma patients and poor clinical outcome. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[51]  James Riddell,et al.  HIV–1 Infects Multipotent Progenitor Cells Causing Cell Death and Establishing Latent Cellular Reservoirs , 2010, Nature Medicine.

[52]  Y. Okada,et al.  The Human Polyoma JC Virus Agnoprotein Acts as a Viroporin , 2010, PLoS pathogens.

[53]  E. Major,et al.  Characterization of JC human polyomavirus infection in a Portuguese population , 2010, Journal of medical virology.

[54]  J. McCutchan,et al.  Unmasking of PML by HAART: Unusual clinical features and the role of IRIS , 2010, Journal of Neuroimmunology.

[55]  H. Reichmann,et al.  CD49d blockade by natalizumab in patients with multiple sclerosis affects steady-state hematopoiesis and mobilizes progenitors with a distinct phenotype and function , 2010, Bone Marrow Transplantation.

[56]  E. Major.  Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies. , 2010, Annual review of medicine.

[57]  C. Boland,et al.  JC Virus Mediates Invasion and Migration in Colorectal Metastasis , 2009, PloS one.

[58]  K. Khalili,et al.  Modulation of JC virus transcription by C/EBPbeta. , 2009, Virus research.

[59]  Hiroyuki Yamamoto,et al.  Genetic and epigenetic characteristics of gastric cancers with JC virus T-antigen. , 2009, World journal of gastroenterology.

[60]  B. Brew,et al.  POSSIBLE JCV GRANULAR CELL NEURONOPATHY IN A PATIENT WITH HIV INFECTION , 2009, Neurology.

[61]  D. Clifford,et al.  Determinants of survival in progressive multifocal leukoencephalopathy , 2009, Neurology.

[62]  Tadaki Suzuki,et al.  Large T Antigen Promotes JC Virus Replication in G2-arrested Cells by Inducing ATM- and ATR-mediated G2 Checkpoint Signaling* , 2009, The Journal of Biological Chemistry.

[63]  E. Major,et al.  Monoclonal antibodies and progressive multifocal leukoencephalopathy , 2009, mAbs.

[64]  S. Sugiura,et al.  Archetype JC virus efficiently propagates in kidney‐derived cells stably expressing HIV‐1 Tat , 2009, Microbiology and immunology.

[65]  I. Koralnik,et al.  Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppression , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[66]  R. Collman,et al.  CNS Inflammation and Macrophage/Microglial Biology Associated with HIV-1 Infection , 2009, Journal of Neuroimmune Pharmacology.

[67]  T. Takegami,et al.  Inhibitory effect of serotonin antagonists on JC virus propagation in a carrier culture of human neuroblastoma cells , 2009, Microbiology and immunology.

[68]  D. West,et al.  Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project. , 2009, The Lancet. Oncology.

[69]  K. Khalili,et al.  SMAD proteins of oligodendroglial cells regulate transcription of JC virus early and late genes coordinately with the Tat protein of human immunodeficiency virus type 1. , 2009, The Journal of general virology.

[70]  M. Churchill,et al.  Extensive astrocyte infection is prominent in human immunodeficiency virus–associated dementia , 2009, Annals of neurology.

[71]  M. Barnett,et al.  What lies beneath the tent? JC-virus cerebellar granule cell neuronopathy complicating sarcoidosis , 2009, Journal of Clinical Neuroscience.

[72]  K. Khalili,et al.  Generation and characterization of JCV permissive hybrid cell lines. , 2009, Journal of virological methods.

[73]  D. Graham,et al.  Polyomavirus Shedding in the Stool of Healthy Adults , 2009, Journal of Clinical Microbiology.

[74]  M. Wilhelm,et al.  Detection of human viruses in rivers of a densly-populated area in Germany using a virus adsorption elution method optimized for PCR analyses. , 2009, Water research.

[75]  Matthew P. Anderson,et al.  Fulminant JC virus encephalopathy with productive infection of cortical pyramidal neurons , 2009, Annals of neurology.

[76]  David Green,et al.  Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. , 2009, Blood.

[77]  K. Khalili,et al.  Hypoxia inducible factor-1 alpha activation of the JCV promoter: role in the pathogenesis of Progressive Multifocal Leukoencephalopathy , 2009, Acta Neuropathologica.

[78]  B. Brew.  Faculty Opinions recommendation of PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids. , 2009 .

[79]  J. Paul,et al.  Quantification of Human Polyomaviruses JC Virus and BK Virus by TaqMan Quantitative PCR and Comparison to Other Water Quality Indicators in Water and Fecal Samples , 2009, Applied and Environmental Microbiology.

[80]  A. Nath,et al.  Role of Tat Protein in HIV Neuropathogenesis , 2009, Neurotoxicity Research.

[81]  I. Koralnik,et al.  Detection of JC virus DNA and proteins in the bone marrow of HIV-positive and HIV-negative patients: implications for viral latency and neurotropic transformation. , 2009, The Journal of infectious diseases.

[82]  Jeffrey M Weinberg,et al.  Patient fatalities potentially associated with efalizumab use. , 2009, Journal of drugs in dermatology : JDD.

[83]  E. Concia,et al.  Mirtazapine in an HIV-1 infected patient with progressive multifocal leukoencephalopathy. , 2009, Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive.

[84]  S. Moreno,et al.  Treatment options for AIDS patients with progressive multifocal leukoencephalopathy , 2009, Expert opinion on pharmacotherapy.

[85]  S. Sunyaev,et al.  Adaptive Mutations in the JC Virus Protein Capsid Are Associated with Progressive Multifocal Leukoencephalopathy (PML) , 2009, PLoS genetics.

[86]  S. Kesari,et al.  Frequent Infection of Cerebellar Granule Cell Neurons by Polyomavirus JC in Progressive Multifocal Leukoencephalopathy , 2009, Journal of neuropathology and experimental neurology.

[87]  P. Ferrante,et al.  Presence and expression of JCV early gene large T Antigen in the brains of immunocompromised and immunocompetent individuals , 2008, Journal of medical virology.

[88]  J. Cinatl,et al.  The impact of treatment with tumour necrosis factor‐α antagonists on the course of chronic viral infections: a review of the literature , 2008, The British journal of dermatology.

[89]  L. Agodoa,et al.  Progressive multifocal leukoencephalopathy and use of mycophenolate mofetil after kidney transplantation. , 2008, Transplantation.

[90]  S. Mkrtchian,et al.  The C-Terminal Domain of ERp29 Mediates Polyomavirus Binding, Unfolding, and Infection , 2008, Journal of Virology.

[91]  M. Krumbholz,et al.  Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis , 2008, Neurology.

[92]  M. Selgrad,et al.  JC Virus Infection in Colorectal Neoplasia That Develops after Liver Transplantation , 2008, Clinical Cancer Research.

[93]  Laarni Sumibcay,et al.  Serotonin receptor 2A blocker (risperidone) has no effect on human polyomavirus JC infection of primary human fetal glial cells , 2008, Journal of NeuroVirology.

[94]  S. Croul,et al.  Detection of JC virus DNA fragments but not proteins in normal brain tissue , 2008, Annals of neurology.

[95]  Wen-Cheng Chen,et al.  Prevalence and genotype identification of human JC virus in colon cancer in Taiwan , 2008, Journal of medical virology.

[96]  K. Khalili,et al.  Potential Mechanisms of the Human Polyomavirus JC in Neural Oncogenesis , 2008, Journal of neuropathology and experimental neurology.

[97]  B. O'Hara,et al.  Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitor Cells Express the Serotonin Receptor and Are Susceptible to JC Virus Infection , 2008, Journal of Virology.

[98]  K. Khalili,et al.  Early growth response-1 protein is induced by JC virus infection and binds and regulates the JC virus promoter. , 2008, Virology.

[99]  K. Khalili,et al.  Dephosphorylation of JC virus agnoprotein by protein phosphatase 2A: inhibition by small t antigen. , 2008, Virology.

[100]  E. Major,et al.  DNA-binding transcription factor NF-1A negatively regulates JC virus multiplication , 2008, The Journal of general virology.

[101]  Allen J Aksamit,et al.  Progressive multifocal leukoencephalopathy , 2008, Continuum.

[102]  M. Fehlings,et al.  Molecular mechanisms of Fas-mediated cell death in oligodendrocytes. , 2008, Journal of neurotrauma.

[103]  James G Krueger,et al.  Blockade of CD11a by efalizumab in psoriasis patients induces a unique state of T-cell hyporesponsiveness. , 2008, The Journal of investigative dermatology.

[104]  K. Khalili,et al.  Role of Puralpha in the modulation of homologous recombination-directed DNA repair by HIV-1 Tat. , 2008, Anticancer research.

[105]  K. Khalili,et al.  Small tumor antigen of polyomaviruses: Role in viral life cycle and cell transformation , 2008, Journal of cellular physiology.

[106]  D. Focosi,et al.  Progressive multifocal leukoencephalopathy: report of three cases in HIV-negative hematological patients and review of literature , 2008, Annals of Hematology.

[107]  P. Randhawa,et al.  Measurements of global cell-mediated immunity in renal transplant recipients with BK virus reactivation. , 2008, American journal of clinical pathology.

[108]  C. Duyckaerts,et al.  Promyelocytic Leukemia Nuclear Bodies Provide a Scaffold for Human Polyomavirus JC Replication and Are Disrupted After Development of Viral Inclusions in Progressive Multifocal Leukoencephalopathy , 2008, Journal of neuropathology and experimental neurology.

[109]  Kai-Hsin Chang,et al.  Increased numbers of circulating hematopoietic stem/progenitor cells are chronically maintained in patients treated with the CD49d blocking antibody natalizumab. , 2008, Blood.

[110]  H. Hartung,et al.  The monoclonal anti-VLA-4 antibody natalizumab mobilizes CD34+ hematopoietic progenitor cells in humans. , 2008, Blood.

[111]  Thilo Stehle,et al.  Structural basis of GM1 ganglioside recognition by simian virus 40 , 2008, Proceedings of the National Academy of Sciences.

[112]  B. O'Hara,et al.  Interferon beta1-a and selective anti-5HT(2a) receptor antagonists inhibit infection of human glial cells by JC virus. , 2008, Virus research.

[113]  L. Kappos,et al.  Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients , 2008, Journal of Neuroimmunology.

[114]  G. Ehninger,et al.  Chlorpromazine Combined with Cidofovir for Treatment of a Patient Suffering from Progressive Multifocal Leukoencephalopathy , 2008, Intervirology.

[115]  S. Allegrini,et al.  Latent human polyomavirus infection in pregnancy: investigation of possible transplacental transmission , 2008, Pathology.

[116]  W. Atwood,et al.  Direct Correlation between Sialic Acid Binding and Infection of Cells by Two Human Polyomaviruses (JC Virus and BK Virus) , 2007, Journal of Virology.

[117]  P. Revy,et al.  V(D)J and immunoglobulin class switch recombinations: a paradigm to study the regulation of DNA end-joining , 2007, Oncogene.

[118]  Mario Schelhaas,et al.  Simian Virus 40 Depends on ER Protein Folding and Quality Control Factors for Entry into Host Cells , 2007, Cell.

[119]  M. Molinari,et al.  In and out of the ER: protein folding, quality control, degradation, and related human diseases. , 2007, Physiological reviews.

[120]  Billy Tsai,et al.  A Chaperone-Activated Nonenveloped Virus Perforates the Physiologically Relevant Endoplasmic Reticulum Membrane , 2007, Journal of Virology.

[121]  Anne Imberty,et al.  N-Glycolyl GM1 Ganglioside as a Receptor for Simian Virus 40 , 2007, Journal of Virology.

[122]  P. Stattin,et al.  No excess risk for colorectal cancer among subjects seropositive for the JC polyomavirus , 2007, International journal of cancer.

[123]  R. Ransohoff.  “Thinking without thinking” about natalizumab and PML , 2007, Journal of the Neurological Sciences.

[124]  K. Khalili,et al.  Alterations of DNA damage repair pathways resulting from JCV infection. , 2007, Virology.

[125]  V. Nerurkar,et al.  Polyomavirus JC infects human brain microvascular endothelial cells independent of serotonin receptor 2A. , 2007, Virology.

[126]  R. Everett,et al.  PML and PML nuclear bodies: implications in antiviral defence. , 2007, Biochimie.

[127]  B. Shiramizu,et al.  High prevalence of human polyomavirus JC VP1 gene sequences in pediatric malignancies. , 2007, Cellular and molecular biology.

[128]  Ludwig Kappos,et al.  Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring , 2007, The Lancet Neurology.

[129]  S. Torp,et al.  Progressive multifocal leukoencephalopathy in a lymphoma patient with complete remission after treatment with cytostatics and rituximab: case report and review of the literature. , 2007, Clinical neuropathology.

[130]  Y. Okada,et al.  DDX1 Promotes Proliferation of the JC Virus through Transactivation of Its Promoter , 2007, Microbiology and immunology.

[131]  Yvonne W Wu,et al.  JC virus granule cell neuronopathy in a child with CD40 ligand deficiency. , 2007, Pediatric neurology.

[132]  Y. Okada,et al.  Identification of DDX1 as a JC Virus Transcriptional Control Region‐Binding Protein , 2007, Microbiology and immunology.

[133]  D. Clifford,et al.  Frequency and Phenotype of JC Virus-Specific CD8+ T Lymphocytes in the Peripheral Blood of Patients with Progressive Multifocal Leukoencephalopathy , 2007, Journal of Virology.

[134]  H. Harputluoglu,et al.  Rituximab-related viral infections in lymphoma patients , 2007, Leukemia & lymphoma.

[135]  K. Tsuneyama,et al.  High JC virus load in gastric cancer and adjacent non‐cancerous mucosa , 2007, Cancer science.

[136]  M. J. Tevethia,et al.  JC virus T′135, T′136 and T′165 proteins interact with cellular p107 and p130 in vivo and influence viral transformation potential , 2006, Journal of NeuroVirology.

[137]  A. Giordano,et al.  Analysis of a mutant p53 protein arising in a medulloblastoma from a mouse transgenic for the JC virus early region. , 2006, Anticancer research.

[138]  J. Sedivy,et al.  NFAT4 Is Required for JC Virus Infection of Glial Cells , 2006, Journal of Virology.

[139]  B. O'Hara,et al.  Invasion of Host Cells by JC Virus Identifies a Novel Role for Caveolae in EndosomalSorting of Noncaveolar Ligands , 2006, Journal of Virology.

[140]  K. Khalili,et al.  Cross-Interaction between JC Virus Agnoprotein and Human Immunodeficiency Virus Type 1 (HIV-1) Tat Modulates Transcription of the HIV-1 Long Terminal Repeat in Glial Cells , 2006, Journal of Virology.

[141]  Xin Dang,et al.  A granule cell neuron-associated JC virus variant has a unique deletion in the VP1 gene. , 2006, The Journal of general virology.

[142]  H. Ploegh,et al.  Murine Polyomavirus Requires the Endoplasmic Reticulum Protein Derlin-2 To Initiate Infection , 2006, Journal of Virology.

[143]  A. Giordano,et al.  Role of the interaction between large T antigen and Rb family members in the oncogenicity of JC virus , 2006, Oncogene.

[144]  E. Major,et al.  Interactions between c-Jun, Nuclear Factor 1, and JC Virus Promoter Sequences: Implications for Viral Tropism , 2006, Journal of Virology.

[145]  J. Bogousslavsky,et al.  Favourable outcome of progressive multifocal leucoencephalopathy in two patients with dermatomyositis , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[146]  C. Boland,et al.  Oncogenic T‐antigen of JC virus is present frequently in human gastric cancers , 2006, Cancer.

[147]  Craig S. Miller,et al.  JC virus detection in bodily fluids: clues to transmission. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[148]  E. Major,et al.  Neural progenitors and HIV-1-associated central nervous system disease in adults and children. , 2006, Current HIV research.

[149]  J. Henson,et al.  Irisolidone, an isoflavone metabolite, represses JC virus gene expression via inhibition of Sp1 binding in human glial cells. , 2006, Biochemical and biophysical research communications.

[150]  S. Kesari,et al.  Characterization of lymphocytic infiltrates in progressive multifocal leukoencephalopathy: Co-localization of CD8+ T cells with JCV-infected glial cells , 2006, Journal of NeuroVirology.

[151]  J. Mate,et al.  Rarity of JC virus DNA sequences and early proteins in human gliomas and medulloblastomas: the controversial role of JC virus in human neurooncogenesis , 2006, Neuropathology and applied neurobiology.

[152]  J. Berger,et al.  Progressive multifocal leukoencephalopathy: lessons from AIDS and natalizumab , 2006, Neurological research.

[153]  J. Berman,et al.  HIV tat and neurotoxicity. , 2006, Microbes and infection.

[154]  K. Khalili,et al.  Regulation of human neurotropic JCV in colon cancer cells. , 2006, Anticancer research.

[155]  A. Giordano,et al.  JC virus large T‐antigen and IGF‐I signaling system merge to affect DNA repair and genomic integrity , 2006, Journal of cellular physiology.

[156]  S. Croul,et al.  T‐antigen of the human polyomavirus JC attenuates faithful DNA repair by forcing nuclear interaction between IRS‐1 and Rad51 , 2006, Journal of cellular physiology.

[157]  E. Lazaro,et al.  JC virus meningitis in a patient with systemic lupus erythematosus , 2005, Lupus.

[158]  S. Croul,et al.  Re: Investigation of human brain tumors for the presence of polyomavirus genome sequences by two independent laboratories by Rollison et al. (published online 21 October 2004) , 2005, International journal of cancer.

[159]  M. Baryshev,et al.  ERp29 triggers a conformational change in polyomavirus to stimulate membrane binding. , 2005, Molecular cell.

[160]  A. Giordano,et al.  Investigation on the role of cell transcriptional factor Sp1 and HIV‐1 TAT protein in PML onset or development , 2005, Journal of cellular physiology.

[161]  T. Vesikari,et al.  Genetic diversity of JC virus in the Saami and the Finns: implications for their population history. , 2005, American journal of physical anthropology.

[162]  J. Butel,et al.  Frequent detection of polyomaviruses in stool samples from hospitalized children. , 2005, The Journal of infectious diseases.

[163]  A. De Luca,et al.  Reduced Rate of Diagnostic Positive Detection of JC Virus DNA in Cerebrospinal Fluid in Cases of Suspected Progressive Multifocal Leukoencephalopathy in the Era of Potent Antiretroviral Therapy , 2005, Journal of Clinical Microbiology.

[164]  K. Tyler,et al.  Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. , 2005, The New England journal of medicine.

[165]  S. Atlas,et al.  Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. , 2005, The New England journal of medicine.

[166]  P. Rutgeerts,et al.  Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease. , 2005, The New England journal of medicine.

[167]  W. Hall,et al.  New sequence polymorphisms in the outer loops of the JC polyomavirus major capsid protein (VP1) possibly associated with progressive multifocal leukoencephalopathy. , 2005, The Journal of general virology.

[168]  K. Khalili,et al.  The agnoprotein of polyomaviruses: A multifunctional auxiliary protein , 2005, Journal of cellular physiology.

[169]  P. Calabresi,et al.  Anti-&agr;4 integrin therapy for multiple sclerosis: Mechanisms and rationale , 2005, Neurology.

[170]  A. Antinori,et al.  Macrophage chemoattractant protein-1 levels in cerebrospinal fluid correlate with containment of JC virus and prognosis of acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy , 2005, Journal of NeuroVirology.

[171]  A. Gurtman,et al.  JC virus granule cell neuronopathy: A novel clinical syndrome distinct from progressive multifocal leukoencephalopathy , 2005, Annals of neurology.

[172]  A. Lazzarin,et al.  Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[173]  F. Gray,et al.  Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy , 2005, Acta Neuropathologica.

[174]  P. Visca,et al.  Presence and incidence of DNA sequences of human polyomaviruses BKV and JCV in colorectal tumor tissues. , 2005, Anticancer research.

[175]  Jean Hou,et al.  Investigation of human brain tumors for the presence of polyomavirus genome sequences by two independent laboratories , 2005, International journal of cancer.

[176]  H. Parkman,et al.  Detection of JC virus DNA sequences and expression of viral T antigen and agnoprotein in esophageal carcinoma , 2005, Cancer.

[177]  K. Khalili,et al.  Internalization of exogenous human immunodeficiency virus-1 protein, Tat, by KG-1 oligodendroglioma cells followed by stimulation of DNA replication initiated at the JC virus origin. , 2004, DNA and cell biology.

[178]  M. Kramer,et al.  Progressive multifocal leukoencephalopathy in transplant recipients , 2004, Transplant international : official journal of the European Society for Organ Transplantation.

[179]  B. Roth,et al.  The Human Polyomavirus, JCV, Uses Serotonin Receptors to Infect Cells , 2004, Science.

[180]  E. Major,et al.  Comparison of PCR-southern hybridization and quantitative real-time PCR for the detection of JC and BK viral nucleotide sequences in urine and cerebrospinal fluid. , 2004, Journal of virological methods.

[181]  J. Rockstroh,et al.  Progressive Multifocal Leukencephalopathy in Patients on Highly Active Antiretroviral Therapy: Survival and Risk Factors of Death , 2004, Journal of acquired immune deficiency syndromes.

[182]  Kotaro Yasui,et al.  Major and Minor Capsid Proteins of Human Polyomavirus JC Cooperatively Accumulate to Nuclear Domain 10 for Assembly into Virions , 2004, Journal of Virology.

[183]  K. Khalili,et al.  Role of JC Virus Agnoprotein in DNA Repair , 2004, Journal of Virology.

[184]  P. Lønning,et al.  PML-nuclear bodies accumulate DNA in response to polyomavirus BK and simian virus 40 replication. , 2004, Experimental cell research.

[185]  D. Maric,et al.  Human Immunodeficiency Virus Type 1 Infection of Human Brain-Derived Progenitor Cells , 2004, Journal of Virology.

[186]  K. Khalili,et al.  JCV T-antigen interacts with the neurofibromatosis type 2 gene product in a transgenic mouse model of malignant peripheral nerve sheath tumors , 2004, Oncogene.

[187]  K. Khalili,et al.  Polyomaviruses and human cancer: molecular mechanisms underlying patterns of tumorigenesis. , 2004, Virology.

[188]  C. Ryschkewitsch,et al.  Chinese Strains (Type 7) of JC Virus Are Afro-Asiatic in Origin But Are Phylogenetically Distinct from the Mongolian and Indian Strains (Type 2D) and the Korean and Japanese Strains (Type 2A) , 2004, Journal of Molecular Evolution.

[189]  J. Potter,et al.  No evidence of an association of JC virus and colon neoplasia. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[190]  J. Miklossy,et al.  Primary Central Nervous System Lymphoma Expressing the Human Neurotropic Polyomavirus, JC Virus, Genome , 2004, Journal of Virology.

[191]  A. Mocroft,et al.  Changing incidence of central nervous system diseases in the EuroSIDA cohort , 2004, Annals of neurology.

[192]  T. Kitamura,et al.  Stability of JC virus coding sequences in a case of progressive multifocal leukoencephalopathy in which the viral control region was rearranged markedly. , 2004, Archives of pathology & laboratory medicine.

[193]  K. Khalili,et al.  Evidence for involvement of transforming growth factor beta1 signaling pathway in activation of JC virus in human immunodeficiency virus 1-associated progressive multifocal leukoencephalopathy. , 2004, Archives of pathology & laboratory medicine.

[194]  T. Kitamura,et al.  Unambiguous identification of JC polyomavirus strains transmitted from parents to children , 2004, Archives of Virology.

[195]  H. Iwase,et al.  Trial for the geographical identification using JC viral genotyping in Japan. , 2004, Forensic science international.

[196]  P. P. Di Fiore,et al.  A JC Virus-Induced Signal Is Required for Infection of Glial Cells by a Clathrin- and eps15-Dependent Pathway , 2004, Journal of Virology.

[197]  T. Shimizu,et al.  Comparison of PCR-amplified JC virus control region sequences from multiple brain regions in PML , 2003, Neurology.

[198]  A. Helenius,et al.  Ganglioside‐dependent cell attachment and endocytosis of murine polyomavirus‐like particles , 2003, FEBS letters.

[199]  M. Lebwohl,et al.  A novel targeted T-cell modulator, efalizumab, for plaque psoriasis. , 2003, The New England journal of medicine.

[200]  M. Kuroda,et al.  Low Frequency of Cytotoxic T Lymphocytes against the Novel HLA-A*0201-Restricted JC Virus Epitope VP1p36 in Patients with Proven or Possible Progressive Multifocal Leukoencephalopathy , 2003, Journal of Virology.

[201]  U. de Girolami,et al.  Productive infection of cerebellar granule cell neurons by JC virus in an HIV+ individual , 2003, Neurology.

[202]  N. Andrews,et al.  Population‐based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40 , 2003, Journal of medical virology.

[203]  Thilo Stehle,et al.  Gangliosides are receptors for murine polyoma virus and SV40 , 2003, The EMBO journal.

[204]  J. Berger.  JCV-specific CD4 T cell response: another piece of the puzzle in explaining some aspects of AIDS associated PML. , 2003, AIDS.

[205]  J. Delfraissy,et al.  Critical role of JC virus-specific CD4 T-cell responses in preventing progressive multifocal leukoencephalopathy , 2003, AIDS.

[206]  D. Hommes,et al.  Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease. , 2003, Gastroenterology.

[207]  K. Khalili,et al.  Members of the AP-1 Family, c-Jun and c-Fos, Functionally Interact with JC Virus Early Regulatory Protein Large T Antigen , 2003, Journal of Virology.

[208]  E. Major,et al.  Lineage pathway of human brain progenitor cells identified by JC virus susceptability , 2003, Annals of neurology.

[209]  A. Pavesi.  African Origin of Polyomavirus JC and Implications for Prehistoric Human Migrations , 2003, Journal of Molecular Evolution.

[210]  W. Keitel,et al.  Polyomavirus JCV excretion and genotype analysis in HIV-infected patients receiving highly active antiretroviral therapy , 2003, AIDS.

[211]  K. Shah,et al.  Serological Cross-Reactivities between Antibodies to Simian Virus 40, BK Virus, and JC Virus Assessed by Virus-Like-Particle-Based Enzyme Immunoassays , 2003, Clinical Diagnostic Laboratory Immunology.

[212]  K. Khalili,et al.  Regulation of Human Polyomavirus JC Virus Gene Transcription by AP-1 in Glial Cells , 2003, Journal of Virology.

[213]  W. Atwood,et al.  Oligosaccharides as Receptors for JC Virus , 2002, Journal of Virology.

[214]  I. Koralnik.  Overview of the cellular immunity against JC virus in progressive multifocal leukoencephalopathy. , 2002, Journal of neurovirology.

[215]  S. Croul,et al.  Insulin-like growth factor I receptor signaling system in JC virus T antigen-induced primitive neuroectodermal tumors--medulloblastomas. , 2002, Journal of neurovirology.

[216]  J. Palazzo,et al.  Association of human polyomavirus JCV with colon cancer: evidence for interaction of viral T-antigen and beta-catenin. , 2002, Cancer research.

[217]  S. Deventer,et al.  Treating Crohn's Disease by Inducing T Lymphocyte Apoptosis , 2002, Annals of the New York Academy of Sciences.

[218]  Jennie Queen-Baker,et al.  A pilot study of cidofovir for progressive multifocal leukoencephalopathy in AIDS , 2002, AIDS.

[219]  W. Atwood,et al.  Construction of a novel JCV/SV40 hybrid virus (JCSV) reveals a role for the JCV capsid in viral tropism. , 2002, Virology.

[220]  A. Giordano,et al.  Evidence for dysregulation of cell cycle by human polyomavirus, JCV, late auxiliary protein , 2002, Oncogene.

[221]  J. Cyster,et al.  Integrin-Mediated Long-Term B Cell Retention in the Splenic Marginal Zone , 2002, Science.

[222]  S. Pomeroy,et al.  Medulloblastomas and primitive neuroectodermal tumors rarely contain polyomavirus DNA sequences. , 2002, Neuro-oncology.

[223]  Jonathan Scott Friedlaender,et al.  JC Virus Genotypes in the Western Pacific Suggest Asian Mainland Relationships and Virus Association with Early Population Movements , 2002, Human biology.

[224]  K. Khalili,et al.  JC virus in Experimental and Clinical Brain Tumorigenesis , 2002 .

[225]  S. Croul,et al.  Insulin Receptor Substrate 1 Translocation to the Nucleus by the Human JC Virus T-antigen* , 2002, The Journal of Biological Chemistry.

[226]  K. Khalili,et al.  Functional Interaction between JC Virus Late Regulatory Agnoprotein and Cellular Y-Box Binding Transcription Factor, YB-1 , 2002, Journal of Virology.

[227]  S. Croul,et al.  Expression of human neurotropic polyomavirus JCV late gene product agnoprotein in human medulloblastoma. , 2002, Journal of the National Cancer Institute.

[228]  A. Pecora,et al.  Unusual viral infections (progressive multifocal leukoencephalopathy and cytomegalovirus disease) after high-dose chemotherapy with autologous blood stem cell rescue and peritransplantation rituximab. , 2002, Blood.

[229]  Jonathan Scott Friedlaender,et al.  New JC virus (JCV) genotypes from Papua New Guinea and Micronesia (Type 8 and Type 2E) and evolutionary analysis of 32 complete JCV genomes , 2001, Archives of Virology.

[230]  G. Maul,et al.  Cellular proteins localized at and interacting within ND10/PML nuclear bodies/PODs suggest functions of a nuclear depot , 2001, Oncogene.

[231]  E. Major,et al.  JC Virus Multiplication in Human Hematopoietic Progenitor Cells Requires the NF-1 Class D Transcription Factor , 2001, Journal of Virology.

[232]  S. Croul,et al.  Expression of a human polyomavirus oncoprotein and tumour suppressor proteins in medulloblastomas , 2001, Molecular pathology : MP.

[233]  K. Khalili,et al.  Physical and functional interaction between viral and cellular proteins modulate JCV gene transcription , 2001, Journal of NeuroVirology.

[234]  G. Gallia,et al.  Coordinate effects of human immunodeficiency virus type 1 protein Tat and cellular protein Puralpha on DNA replication initiated at the JC virus origin. , 2001, The Journal of general virology.

[235]  Y. Sawamura,et al.  JC virus large T protein transforms rodent cells but is not involved in human medulloblastoma , 2001, Neuropathology : official journal of the Japanese Society of Neuropathology.

[236]  S. Croul,et al.  Detection of JC virus DNA sequences and expression of the viral regulatory protein T-antigen in tumors of the central nervous system. , 2001, Cancer research.

[237]  H. Petry,et al.  Cellular and humoral immune response in progressive multifocal leukoencephalopathy , 2001, Annals of neurology.

[238]  N. Letvin,et al.  JC Virus-Specific Cytotoxic T Lymphocytes in Individuals with Progressive Multifocal Leukoencephalopathy , 2001, Journal of Virology.

[239]  M. Wegner.  Expression of transcription factors during oligodendroglial development , 2001, Microscopy research and technique.

[240]  C. Boland,et al.  Mad-1 Is the Exclusive JC Virus Strain Present in the Human Colon, and Its Transcriptional Control Region Has a Deleted 98-Base-Pair Sequence in Colon Cancer Tissues , 2001, Journal of Virology.

[241]  J. Icart,et al.  JC virus genotypes in France: molecular epidemiology and potential significance for progressive multifocal leukoencephalopathy. , 2001, The Journal of infectious diseases.

[242]  C. Ryschkewitsch,et al.  JC virus as a marker of human migration to the Americas. , 2000, Microbes and infection.

[243]  P. Tegtmeyer,et al.  Replication but Not Transcription of Simian Virus 40 DNA Is Dependent on Nuclear Domain 10 , 2000, Journal of Virology.

[244]  A. De Luca,et al.  The effect of potent antiretroviral therapy and JC virus load in cerebrospinal fluid on clinical outcome of patients with AIDS-associated progressive multifocal leukoencephalopathy. , 2000, The Journal of infectious diseases.

[245]  M. Wegner,et al.  Human cytomegalovirus immediate-early gene 2 expression leads to JCV replication in nonpermissive cells via transcriptional activation of JCV T antigen. , 2000, Virology.

[246]  R. Frisque,et al.  Purified JC virus T and T' proteins differentially interact with the retinoblastoma family of tumor suppressor proteins. , 2000, Virology.

[247]  N. Tubridy,et al.  Unsuccessful treatment with cidofovir and cytarabine in progressive multifocal leukoencephalopathy associated with dermatomyositis , 2000, Journal of the Royal Society of Medicine.

[248]  Jonathan Scott Friedlaender,et al.  Human polyomavirus JC variants in Papua New Guinea and Guam reflect ancient population settlement and viral evolution. , 2000, Microbes and infection.

[249]  R. Gronostajski,et al.  Roles of the NFI/CTF gene family in transcription and development. , 2000, Gene.

[250]  C. Ryschkewitsch,et al.  Influence of JC virus coding region genotype on risk of multiple sclerosis and progressive multifocal leukoencephalopathy. , 2000, Journal of neurovirology.

[251]  W. Atwood,et al.  JC Virus Enters Human Glial Cells by Clathrin-Dependent Receptor-Mediated Endocytosis , 2000, Journal of Virology.

[252]  A. Andersen,et al.  Cerebrovascular changes in the basal ganglia with HIV dementia , 2000, Neurology.

[253]  M. M. Pater,et al.  BAG-1, a novel Bcl-2-interacting protein, activates expression of human JC virus. , 2000, The Journal of general virology.

[254]  N. Mermod,et al.  The Histone-interacting Domain of Nuclear Factor I Activates Simian Virus 40 DNA Replication in Vivo * , 2000, The Journal of Biological Chemistry.

[255]  J. Henson,et al.  Glial Cell-Specific Regulation of the JC Virus Early Promoter by Large T Antigen , 2000, Journal of Virology.

[256]  E. Major,et al.  Comparison of Antibody Titers Determined by Hemagglutination Inhibition and Enzyme Immunoassay for JC Virus and BK Virus , 2000, Journal of Clinical Microbiology.

[257]  G. Gallia,et al.  Physical and Functional Interaction between the Y-Box Binding Protein YB-1 and Human Polyomavirus JC Virus Large T Antigen , 1999, Journal of Virology.

[258]  G. Schuierer,et al.  [Cidofovir (vistide) in therapy of progressive multifocal leukoencephalopathy in AIDS. Review of the literature and report of 2 cases]. , 1999, Der Nervenarzt.

[259]  J Gordon,et al.  Detection of human neurotropic JC virus DNA sequence and expression of the viral oncogenic protein in pediatric medulloblastomas. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[260]  J. Weiss,et al.  HIV-1 Tat induces monocyte chemoattractant protein-1-mediated monocyte transmigration across a model of the human blood-brain barrier and up-regulates CCR5 expression on human monocytes. , 1999, Journal of immunology.

[261]  P. Vliet,et al.  Mechanism of DNA replication in eukaryotic cells: cellular host factors stimulating adenovirus DNA replication. , 1999 .

[262]  C. Boland,et al.  JC virus DNA is present in the mucosa of the human colon and in colorectal cancers. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[263]  E. Major,et al.  Viral variant nucleotide sequences help expose leukocytic positioning in the JC virus pathway to the CNS , 1999, Journal of leukocyte biology.

[264]  G. Gallia,et al.  Reciprocal Interaction between Two Cellular Proteins, Purα and YB-1, Modulates Transcriptional Activity of JCVCY in Glial Cells , 1999, Molecular and Cellular Biology.

[265]  S. Croul,et al.  Molecular pathway involved in HIV‐1‐induced CNS pathology: role of viral regulatory protein, Tat , 1999, Journal of leukocyte biology.

[266]  A. Antinori,et al.  Clinical and virological monitoring during treatment with intrathecal cytarabine in patients with AIDS-associated progressive multifocal leukoencephalopathy. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[267]  Kamel Khalili,et al.  Human ubiquitous JCV(CY) T-antigen gene induces brain tumors in experimental animals , 1999, Oncogene.

[268]  E. Major,et al.  The JC and BK human polyoma viruses appear to be recent introductions to some South American Indian tribes: there is no serological evidence of cross-reactivity with the simian polyoma virus SV40. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[269]  Spyros A. Kalams,et al.  The Critical Need for CD4 Help in Maintaining Effective Cytotoxic T Lymphocyte Responses , 1998, The Journal of experimental medicine.

[270]  E. Major,et al.  Detection of JC Virus DNA in Human Tonsil Tissue: Evidence for Site of Initial Viral Infection , 1998, Journal of Virology.

[271]  R. Levy,et al.  Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[272]  J. Neel.  An association, in adult Japanese, between the occurrence of rogue cells among cultured lymphocytes (JC virus activity) and the frequency of "simple" chromosomal damage among the lymphocytes of persons exhibiting these rogue cells. , 1998, American journal of human genetics.

[273]  H. Stellbrink,et al.  Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV‐associated progressive multifocal leukoencephalopathy , 1998, AIDS.

[274]  N. Aoki,et al.  Archetype JC Virus Efficiently Replicates in COS-7 Cells, Simian Cells Constitutively Expressing Simian Virus 40 T Antigen , 1998, Journal of Virology.

[275]  W. Atwood,et al.  Infection of Glial Cells by the Human Polyomavirus JC Is Mediated by an N-Linked Glycoprotein Containing Terminal α(2-6)-Linked Sialic Acids , 1998, Journal of Virology.

[276]  U. Dafni,et al.  Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team. , 1998, The New England journal of medicine.

[277]  J. Alwine,et al.  Simian Virus 40 Large T Antigen Interacts with Human TFIIB-Related Factor and Small Nuclear RNA-Activating Protein Complex for Transcriptional Activation of TATA-Containing Polymerase III Promoters , 1998, Molecular and Cellular Biology.

[278]  C. Ryschkewitsch,et al.  Asian genotypes of JC virus in Native Americans and in a Pacific Island population: markers of viral evolution and human migration. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[279]  R. Knobler,et al.  Role of cell cycle regulators in tumor formation in transgenic mice expressing the human neurotropic virus, JCV, early protein , 1997, Journal of cellular biochemistry.

[280]  M. Wegner,et al.  A cell-free replication system for human polyomavirus JC DNA , 1997, Journal of virology.

[281]  S. Morikawa,et al.  Assembly of JC virus‐like particles in COS7 cells , 1997, Journal of medical virology.

[282]  F. Caprilli,et al.  Detection of JC and BK viral genome in specimens of HIV-1 infected subjects. , 1997, The new microbiologica.

[283]  E. De Clercq,et al.  Activities of various compounds against murine and primate polyomaviruses , 1997, Antimicrobial agents and chemotherapy.

[284]  T. Honjo,et al.  Evidence for regulation of transcription and replication of the human neurotropic virus JCV genome by the human S(mu)bp-2 protein in glial cells. , 1997, Gene.

[285]  M. M. Pater,et al.  Dual NF1-requiring effect of human neurotropic JC virus composite pentanucleotide repeat elements on early and late viral gene expression. , 1997, Virology.

[286]  H. Rollag,et al.  Human cytomegalovirus suppression of and latency in early hematopoietic progenitor cells. , 1996, Blood.

[287]  E. Major,et al.  High titers of antibodies to two human polyomaviruses, JCV and BKV, correlate with increased frequency of chromosomal damage in human lymphocytes. , 1996, Cancer letters.

[288]  L. Chepenik,et al.  Activation of the JC virus Tat-responsive transcriptional control element by association of the Tat protein of human immunodeficiency virus 1 with cellular protein Pur alpha. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[289]  E. Bouza,et al.  Cytarabine therapy for progressive multifocal leukoencephalopathy in patients with AIDS. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[290]  E. Major,et al.  JC virus infection of hematopoietic progenitor cells, primary B lymphocytes, and tonsillar stromal cells: implications for viral latency , 1996, Journal of virology.

[291]  K. Khalili,et al.  Transcriptional regulation of human polyomavirus JC: evidence for a functional interaction between RelA (p65) and the Y-box-binding protein, YB-1 , 1996, Journal of virology.

[292]  M. M. Pater,et al.  Human JC Virus Nuclear Factor 1 Binding Motifs and Large Tumor Antigen Region Required for Transactivation of Late Promoter , 1996, Journal of neurochemistry.

[293]  R. Knobler,et al.  Formation of undifferentiated mesenteric tumors in transgenic mice expressing human neurotropic polymavirus early protein. , 1996, Oncogene.

[294]  G. Gallia,et al.  Evidence that replication of human neurotropic JC virus DNA in glial cells is regulated by the sequence-specific single-stranded DNA-binding protein Pur alpha , 1996, Journal of virology.

[295]  E. Major,et al.  Hypothesis: "Rogue cell"-type chromosomal damage in lymphocytes is associated with infection with the JC human polyoma virus and has implications for oncopenesis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[296]  P. C. Mackeen,et al.  Purified JC virus T antigen derived from insect cells preferentially interacts with binding site II of the viral core origin under replication conditions. , 1996, Virology.

[297]  K. Khalili,et al.  Transcription of the JC virus archetype late genome: importance of the kappa B and the 23-base-pair motifs in late promoter activity in glial cells , 1996, Journal of virology.

[298]  W. Kucharczyk,et al.  Progressive multifocal leukoencephalopathy: clinical and MR response to treatment. , 1996, AJNR. American journal of neuroradiology.

[299]  M. Wegner,et al.  Functional comparison of PML-type and archetype strains of JC virus , 1996, Journal of virology.

[300]  H. Kasamatsu,et al.  Analysis of a nuclear localization signal of simian virus 40 major capsid protein Vp1 , 1996, Journal of virology.

[301]  H. Gendelman,et al.  Mechanisms for the transendothelial migration of HIV-1-infected monocytes into brain. , 1996, Journal of immunology.

[302]  K. Khalili,et al.  Sequences within the early and late promoters of archetype JC virus restrict viral DNA replication and infectivity. , 1996, Virology.

[303]  S. Harrison,et al.  Crystal structures of murine polyomavirus in complex with straight-chain and branched-chain sialyloligosaccharide receptor fragments. , 1996, Structure.

[304]  P. Li,et al.  Association with capsid proteins promotes nuclear targeting of simian virus 40 DNA. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[305]  L. Kanz,et al.  Detection of cytomegalovirus DNA in CD34+ cells from blood and bone marrow. , 1995, Blood.

[306]  J. Ransom.  Mechanism of Action of Mycophenolate Mofetil , 1995, Therapeutic drug monitoring.

[307]  K. Nagashima,et al.  Establishment and characterization of a carrier cell culture producing high titres of polyoma JC virus , 1995, Journal of medical virology.

[308]  K. Khalili,et al.  Transcriptional regulation of human JC polyomavirus promoters by cellular proteins YB-1 and Pur alpha in glial cells , 1995, Journal of virology.

[309]  C. Krebs,et al.  The JC virus minimal core promoter is glial cell specific in vivo , 1995, Journal of virology.

[310]  F. Andermann,et al.  Failure of cytarabine/interferon therapy in progressive multifocal leukoencephalopathy , 1995, Annals of neurology.

[311]  S. Nukuzuma.  [Establishment and analysis of cell culture infected persistently with JC virus]. , 1995, [Hokkaido igaku zasshi] The Hokkaido journal of medical science.

[312]  G. Gallia,et al.  Cooperative action of cellular proteins YB-1 and Pur alpha with the tumor antigen of the human JC polyomavirus determines their interaction with the viral lytic control element. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[313]  R. Ahmed,et al.  CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection , 1994, Journal of virology.

[314]  K. Khalili,et al.  Identification and characterization of a novel GGA/C-binding protein, GBP-i, that is rapidly inducible by cytokines , 1994, Molecular and cellular biology.

[315]  G. Gallia,et al.  Transcription of a human neurotropic virus promoter in glial cells: effect of YB-1 on expression of the JC virus late gene , 1994, Journal of virology.

[316]  R. Frisque,et al.  DNA replication of chimeric JC virus-simian virus 40 genomes. , 1994, Virology.

[317]  B. Levine,et al.  Mefloquine distribution in postmortem cases. , 1994, Forensic science international.

[318]  A. Wildeman,et al.  The kinetics of simian virus 40-induced progression of quiescent cells into S phase depend on four independent functions of large T antigen , 1994, Journal of virology.

[319]  Gerald L. Stoner,et al.  Differential expression of mRNAs for JC virus large and small tumor antigens in brain tissues from progressive multifocal leukoencephalopathy patients with and without AIDS. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[320]  M. Wegner,et al.  The POU domain protein Tst-1 and papovaviral large tumor antigen function synergistically to stimulate glia-specific gene expression of JC virus. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[321]  P. Krammer,et al.  Human immunodeficiency virus type 1 Tat upregulates interleukin-2 secretion in activated T cells , 1994, Journal of virology.

[322]  M. Scerrati,et al.  Failure of cytarabine and increased JC virus-DNA burden in the cerebrospinal fluid of patients with AIDS-related progressive multifocal leucoencephalopathy. , 1994, AIDS.

[323]  C. Shivakumar,et al.  Biochemical and mutational analysis of the polyomavirus core promoter: involvement of nuclear factor-1 in early promoter function. , 1994, The Journal of general virology.

[324]  Thilo Stehle,et al.  Structure of murine polyomavirus complexed with an oligosaccharide receptor fragment , 1994, Nature.

[325]  K. Nagashima,et al.  Propagation of JC virus in human neuroblastoma cell line IMR‐32 , 1994, Journal of medical virology.

[326]  J. Tavis,et al.  Converting the JCV T antigen Rb binding domain to that of SV40 does not alter JCV's limited transforming activity but does eliminate viral viability. , 1994, Virology.

[327]  P. Chinn,et al.  Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. , 1994, Blood.

[328]  J. Henson.  Regulation of the glial-specific JC virus early promoter by the transcription factor Sp1. , 1994, The Journal of biological chemistry.

[329]  P. Rieckmann,et al.  Regulation of JC virus expression in B lymphocytes , 1994, Journal of virology.

[330]  E. Major,et al.  Temporal patterns of human immunodeficiency virus type 1 transcripts in human fetal astrocytes , 1994, Journal of virology.

[331]  B. Scallon,et al.  Construction and initial characterization of a mouse-human chimeric anti-TNF antibody. , 1993, Molecular immunology.

[332]  R. Frisque,et al.  Analysis of G418-selected Rat2 cells containing prototype, variant, mutant, and chimeric JC virus and SV40 genomes. , 1993, Virology.

[333]  G. Ault,et al.  Human polyomavirus JC promoter/enhancer rearrangement patterns from progressive multifocal leukoencephalopathy brain are unique derivatives of a single archetypal structure. , 1993, The Journal of general virology.

[334]  K. Nagashima,et al.  Origin of JC polyomavirus variants associated with progressive multifocal leukoencephalopathy. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[335]  D. Singer,et al.  Repression of MHC class I gene promoter activity by two-exon Tat of HIV. , 1993, Science.

[336]  M. Wegner,et al.  Regulation of JC virus by the POU-domain transcription factor Tst-1: implications for progressive multifocal leukoencephalopathy. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[337]  R. Frisque,et al.  Transcription initiation sites of prototype and variant JC virus early and late messenger RNAs. , 1993, Virology.

[338]  K. Khalili,et al.  The transcriptional enhancer element, kappa B, regulates promoter activity of the human neurotropic virus, JCV, in cells derived from the CNS. , 1993, Nucleic acids research.

[339]  A. Schapira,et al.  Successful outcome of progressive multifocal leukoencephalopathy with cytarabine and interferon , 1993, Annals of neurology.

[340]  K. Khalili,et al.  GA/GC-rich sequence confers Tat responsiveness to human neurotropic virus promoter, JCVL, in cells derived from central nervous system. , 1993, Oncogene.

[341]  K. Dörries,et al.  High frequency of polyomavirus infection in lymphoid cell preparations after allogeneic bone marrow transplantation. , 1993, Transplantation proceedings.

[342]  P. Wingfield,et al.  Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation , 1993, Journal of virology.

[343]  M. M. Pater,et al.  Human JC virus perfect palindromic nuclear factor 1-binding sequences important for glial cell-specific expression in differentiating embryonal carcinoma cells , 1993, Journal of virology.

[344]  H. Kasamatsu,et al.  Role of nuclear pore complex in simian virus 40 nuclear targeting , 1993, Journal of virology.

[345]  J. Taylor,et al.  Evidence that a sequence similar to TAR is important for induction of the JC virus late promoter by human immunodeficiency virus type 1 Tat , 1992, Journal of Virology.

[346]  K. Khalili,et al.  A novel sequence-specific DNA-binding protein, LCP-1, interacts with single-stranded DNA and differentially regulates early gene expression of the human neurotropic JC virus , 1992, Journal of virology.

[347]  C. Petito,et al.  Blood‐brain barrier abnormalities in acquired immunodeficiency syndrome: Immunohistochemical localization of serum proteins in postmortem brain , 1992, Annals of neurology.

[348]  S. Jimenez,et al.  Activation of expression of genes coding for extracellular matrix proteins in Tat-producing glioblastoma cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[349]  G. Ault,et al.  Two major types of JC virus defined in progressive multifocal leukoencephalopathy brain by early and late coding region DNA sequences. , 1992, The Journal of general virology.

[350]  E. Major,et al.  Interaction of the human polyomavirus, JCV, with human B-lymphocytes. , 1992, Virology.

[351]  E. Major,et al.  Adjacent nuclear factor-1 and activator protein binding sites in the enhancer of the neurotropic JC virus. A common characteristic of many brain-specific genes. , 1992, The Journal of biological chemistry.

[352]  D. Pillay,et al.  JC virus associated meningoencephalitis in an immunocompetent girl. , 1992, Archives of disease in childhood.

[353]  J. Saffer,et al.  The transcription factor Sp1 binds to the JC virus promoter and is selectively expressed in glial cells in human brain , 1992, Annals of neurology.

[354]  N. Young,et al.  Infection of hematopoietic progenitor cells by human cytomegalovirus. , 1992, Blood.

[355]  W. Atwood,et al.  Class I major histocompatibility proteins are an essential component of the simian virus 40 receptor , 1992, Journal of virology.

[356]  E. Major,et al.  Detection of JC virus DNA in peripheral lymphocytes from patients with and without progressive multifocal leukoencephalopathy , 1992, Annals of neurology.

[357]  F. Nicoli,et al.  Efficacy of cytarabine in progressive multifocal leucoencephalopathy in AIDS , 1992, The Lancet.

[358]  E. Major,et al.  Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain , 1992, Clinical Microbiology Reviews.

[359]  M. Wells,et al.  The DNA-binding domain of nuclear factor I is sufficient to cooperate with the adenovirus type 2 DNA-binding protein in viral DNA replication. , 1991, The Journal of general virology.

[360]  R. Liddington,et al.  Structure of simian virus 40 at 3.8-Å resolution , 1991, Nature.

[361]  T. Iida,et al.  Typing of human polyomavirus JC virus on the basis of restriction fragment length polymorphisms , 1991, Journal of clinical microbiology.

[362]  J. Brady,et al.  Human immunodeficiency virus Tat transactivation: induction of a tissue-specific enhancer in a nonpermissive cell line , 1991, Journal of virology.

[363]  M. Wegner,et al.  DNA replication of human polyomavirus JC is stimulated by NF-I in vivo. , 1991, Virology.

[364]  J. Hurwitz,et al.  Initiation of simian virus 40 DNA synthesis in vitro , 1991, Molecular and cellular biology.

[365]  P. Algra,et al.  Response to cytarabine in progressive multifocal leucoencephalopathy in AIDS , 1991, The Lancet.

[366]  S. Subramani,et al.  Amplification and sequencing of the control regions of BK and JC virus from human urine by polymerase chain reaction. , 1991, Virology.

[367]  J. Assouline,et al.  Human fetal Schwann cells support JC virus multiplication , 1991, Journal of virology.

[368]  T. Dubensky,et al.  Polyomavirus replication in mice: influences of VP1 type and route of inoculation , 1991, Journal of virology.

[369]  T. Benjamin,et al.  Polyomavirus tumor induction in mice: effects of polymorphisms of VP1 and large T antigen , 1991, Journal of virology.

[370]  E. Major,et al.  Glial cells of the human developing brain and B cells of the immune system share a common DNA binding factor for recognition of the regulatory sequences of the human polyomavirus, JCV , 1990, Journal of neuroscience research.

[371]  J. Taylor,et al.  Regulation of the human neurotropic virus promoter by JCV-T antigen and HIV-1 tat protein. , 1990, Oncogene.

[372]  R. Frisque,et al.  Identification of critical elements within the JC virus DNA replication origin , 1990, Journal of virology.

[373]  C. Verrijzer,et al.  Transcription factors NFI and NFIII/oct-1 function independently, employing different mechanisms to enhance adenovirus DNA replication , 1990, Journal of virology.

[374]  T. Kelly,et al.  Reconstitution of simian virus 40 DNA replication with purified proteins. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[375]  M. Bina,et al.  Location of nucleosomes in simian virus 40 chromatin. , 1990, Journal of molecular biology.

[376]  B. Stillman,et al.  Sequential initiation of lagging and leading strand synthesis by two different polymerase complexes at the SV40 DNA replication origin , 1990, Nature.

[377]  K. Mikoshiba,et al.  A new transcription element in the JC virus enhancer. , 1990, The Journal of general virology.

[378]  J. Hurwitz,et al.  Mechanism of elongation of primed DNA by DNA polymerase delta, proliferating cell nuclear antigen, and activator 1. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[379]  T. Kitamura,et al.  Isolation of a possible archetypal JC virus DNA sequence from nonimmunocompromised individuals , 1990, Journal of virology.

[380]  S. Salahuddin,et al.  Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients , 1990, Nature.

[381]  K. Khalili,et al.  Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[382]  A. Schauer,et al.  Tissue-specific expression of sialyltransferases. , 1989, The Journal of biological chemistry.

[383]  E. Major,et al.  Human Fetal Astrocytes in Culture Support the Growth of the Neurotropic Human Polyomavirus, JCV , 1989, Journal of neuropathology and experimental neurology.

[384]  J. Bodensteiner,et al.  Reversible Treatment-Related Leukoencephalopathy , 1989, Journal of child neurology.

[385]  E. Major,et al.  Extension of JC virus host range to monkey cells by insertion of a simian virus 40 enhancer into the JC virus regulatory region. , 1989, Virology.

[386]  E. Major,et al.  Interaction of a nuclear factor-1-like protein with the regulatory region of the human polyomavirus JC virus. , 1989, The Journal of biological chemistry.

[387]  R. Compans,et al.  Characterization of simian virus 40 receptor moieties on the surfaces of Vero C1008 cells , 1989, Journal of virology.

[388]  R. Frisque,et al.  Hybrid genomes of the polyomaviruses JC virus, BK virus, and simian virus 40: identification of sequences important for efficient transformation , 1989, Journal of virology.

[389]  K. Khalili,et al.  Cell type-specific expression of JC virus early promoter is determined by positive and negative regulation , 1989, Journal of virology.

[390]  D. Walker,et al.  Age distribution of progressive multifocal leukoencephalopathy , 1988, Acta neurologica Scandinavica.

[391]  P. Luciw,et al.  Structural arrangements of transcription control domains within the 5'-untranslated leader regions of the HIV-1 and HIV-2 promoters. , 1988, Genes & development.

[392]  K. Dörries,et al.  DNA rearrangements in organ-specific variants of polyomavirus JC strain GS , 1988, Journal of virology.

[393]  B. Stillman,et al.  Cellular factors required for multiple stages of SV40 DNA replication in vitro. , 1988, The EMBO journal.

[394]  K. Khalili,et al.  Nuclear factors in human brain cells bind specifically to the JCV regulatory region. , 1988, The EMBO journal.

[395]  E. Major,et al.  Unusual DNA structure in the regulatory region of the human papovavirus JC virus , 1988, Journal of virology.

[396]  C. Kufta,et al.  Involvement of JC virus-infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathy. , 1988, The New England journal of medicine.

[397]  M. Post,et al.  Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. A review of the literature with a report of sixteen cases. , 1987, Annals of internal medicine.

[398]  E. Major,et al.  Regulation of the host range of human papovavirus JCV. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[399]  K. Khalili,et al.  Evidence for a shift in 5'-termini of early viral RNA during the lytic cycle of JC virus. , 1987, Virology.

[400]  E. Harley,et al.  Structure and function of the transcriptional control region of nonpassaged BK virus , 1987, Journal of virology.

[401]  E. Major,et al.  Owl monkey astrocytoma cells in culture spontaneously produce infectious JC virus which demonstrates altered biological properties , 1987, Journal of virology.

[402]  C. Mandl,et al.  Derivation and characterization of POJ cells, transformed human fetal glial cells that retain their permissivity for JC virus , 1987, Journal of virology.

[403]  W. Yung,et al.  High dose Ara-C related leukoencephalopathy , 1986, Journal of Neuro-Oncology.

[404]  J. Brady,et al.  Spacing between simian virus 40 early transcriptional control sequences is important for regulation of early RNA synthesis and gene expression , 1986, Journal of virology.

[405]  P. Howley,et al.  Early regions of JC virus and BK virus induce distinct and tissue-specific tumors in transgenic mice. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[406]  A. Stein,et al.  Simian virus 40 protein VP1 is involved in spacing nucleosomes in minichromosomes. , 1986, Journal of molecular biology.

[407]  C. Mandl,et al.  Characterization of cells transformed by the human polyomavirus JC virus. , 1986, The Journal of general virology.

[408]  S. Kenney,et al.  Mapping 5' termini of JC virus early RNAs , 1986, Journal of virology.

[409]  S. Kenney,et al.  Mapping 5' termini of JC virus late RNA , 1986, Journal of virology.

[410]  E. Major,et al.  Progressive multifocal leukoencephalopathy: JC virus detection by in situ hybridization compared with immunohistochemistry , 1986, Neurology.

[411]  E. Major,et al.  JC virus T protein during productive infection in human fetal brain and kidney cells. , 1986, Virology.

[412]  D. Dorsett,et al.  Linear simian virus 40 DNA fragments exhibit a propensity for rolling-circle replication , 1985, Molecular and cellular biology.

[413]  K. Nagashima,et al.  Induction of undifferentiated brain tumors in rats by a human polyomavirus (JC virus). , 1985, Japanese journal of cancer research : Gann.

[414]  D. Dorsett,et al.  Circular and linear simian virus 40 DNAs differ in recombination , 1985, Molecular and cellular biology.

[415]  N. Salzman,et al.  Characterization of a surrogate TATA box promoter that regulates in vitro transcription of the simian virus 40 major late gene , 1985, Molecular and cellular biology.

[416]  E. Major,et al.  Establishment of a line of human fetal glial cells that supports JC virus multiplication. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[417]  R. Frisque,et al.  Differences in regulatory sequences of naturally occurring JC virus variants , 1985, Journal of virology.

[418]  J. D. Martín,et al.  Multiple JC virus genomes from one patient. , 1984, The Journal of general virology.

[419]  E. Major,et al.  JC virus-induced owl monkey glioblastoma cells in culture: biological properties associated with the viral early gene product. , 1984, Virology.

[420]  J. Brady,et al.  Stimulation of simian virus 40 late gene expression by simian virus 40 tumor antigen. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[421]  E. Trifonov,et al.  Nucleotide sequence-directed mapping of the nucleosomes of SV40 chromatin , 1984, Cell Biophysics.

[422]  P. Mckeever,et al.  Brain tumors of owl monkeys inoculated with JC virus contain the JC virus genome , 1984, Journal of virology.

[423]  J. Alwine,et al.  Activation of the SV40 late promoter: Direct effects of T antigen in the absence of viral DNA replication , 1984, Cell.

[424]  J. Paulson,et al.  Sialyloligosaccharide receptors of binding variants of polyoma virus. , 1983, Virology.

[425]  J. Hurwitz,et al.  Specific binding of a cellular DNA replication protein to the origin of replication of adenovirus DNA. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[426]  J. Hurwitz,et al.  Adenovirus DNA replication in vitro: synthesis of full-length DNA with purified proteins. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[427]  R. Frisque.  Nucleotide sequence of the region encompassing the JC virus origin of DNA replication , 1983, Journal of virology.

[428]  E. Soeda,et al.  Genomic structure of human polyoma virus JC: nucleotide sequence of the region containing replication origin and small-T-antigen gene , 1983, Journal of virology.

[429]  J. Brady,et al.  Site-specific base substitution and deletion mutations that enhance or suppress transcription of the SV40 major late RNA , 1982, Cell.

[430]  J. Hurwitz,et al.  Adenovirus DNA replication in vitro: identification of a host factor that stimulates synthesis of the preterminal protein-dCMP complex. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[431]  P. Fishman,et al.  Biosynthesis and localization of gangliosides in cultured cells. , 1982, Biochemistry.

[432]  D. Gilden,et al.  Demonstration of JC virus by immunofluorescence in multiple cell types in experimentally infected adult human brain cell cultures , 1982, Journal of the Neurological Sciences.

[433]  S. Stagno,et al.  Serological Investigation of the possibility of congenital transmission of papovavirus JC , 1981, Infection and immunity.

[434]  J. Paulson,et al.  Polyoma virus recognizes specific sialyligosaccharide receptors on host cells. , 1981, Virology.

[435]  J. Sambrook,et al.  Expression of early genes of origin-defective mutants of simian virus 40. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[436]  J. Paulson,et al.  Polyoma virus adsorbs to specific sialyloligosaccharide receptors on erythrocytes. , 1980, Virology.

[437]  G. Khoury,et al.  The genome of human papovavirus BKV , 1979, Cell.

[438]  Ray Wu,et al.  Comparative study of papovavirus DNA: BKV(MM), BKV(WT) and SV40. , 1979, Nucleic acids research.

[439]  P. Howley,et al.  The colinear alignment of the genomes of papovaviruses JC, BK, and SV40. , 1979, Virology.

[440]  T. Ohashi,et al.  Brain tumors in owl monkeys inoculated with a human polyomavirus (JC virus). , 1978, Science.

[441]  H. Hausen,et al.  BK virus: I. Seroepidemiologic studies and serologic response to viral infection , 1978, Medical Microbiology and Immunology.

[442]  R. Contreras,et al.  Complete nucleotide sequence of SV40 DNA , 1978, Nature.

[443]  S. Weissman,et al.  The genome of simian virus 40. , 1978, Science.

[444]  T. Merigan,et al.  Adenine arabinoside in the treatment of progressive multifocal leukoencephalopathy: Use of virus‐containing cells in the urine to assess response to therapy , 1977, Annals of neurology.

[445]  J. Varakis,et al.  Differential neurooncogenicity of strains of JC virus, a human polyoma virus, in newborn Syrian hamsters. , 1977, Cancer research.

[446]  R. Laskey,et al.  Assembly of SV40 chromatin in a cell-free system from Xenopus eggs , 1977, Cell.

[447]  R. Buckman,et al.  PROGRESSIVE MULTIFOCAL LEUCOENCEPHALOPATHY SUCCESSFULLY TREATED WITH CYTOSINE ARABINOSIDE , 1976 .

[448]  P. Brown,et al.  Seroepidemiology of human papovaviruses. Discovery of virgin populations and some unusual patterns of antibody prevalence among remote peoples of the world. , 1975, American journal of epidemiology.

[449]  I. Janota,et al.  Progressive multifocal leucoencephalopathy: remission with cytarabine. , 1975, Journal of neurology, neurosurgery, and psychiatry.

[450]  T. Vogel,et al.  The interaction of histones with simian virus 40 supercoiled circular deoxyribonucleic acid in vitro. , 1975, The Journal of biological chemistry.

[451]  U. Roessmann,et al.  Cytarabine treatment of progressive multifocal leukoencephalopathy. Clinical course and detection of virus-like particles after antiviral chemotherapy. , 1974, JAMA.

[452]  B. Weisblum,et al.  Comparison of JC and BK Human Papovaviruses with Simian Virus 40: Restriction Endonuclease Digestion and Gel Electrophoresis of Resultant Fragments , 1974, Journal of virology.

[453]  B. Padgett,et al.  Human Papovavirus (JC): Induction of Brain Tumors in Hamsters , 1973, Science.

[454]  B. Padgett,et al.  Prevalence of antibodies in human sera against JC virus, an isolate from a case of progressive multifocal leukoencephalopathy. , 1973, The Journal of infectious diseases.

[455]  B. Padgett,et al.  Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. , 1971, Lancet.

[456]  G. ZuRhein,et al.  POLYOMA-LIKE VIRIONS IN HUMAN DEMYELINATING BRAIN DISEASE. , 1965, Canadian Medical Association journal.

[457]  G. Z. Zu Rhein,et al.  Particles Resembling Papova Viruses in Human Cerebral Demyelinating Disease , 1965, Science.

[458]  J. Cavanagh,et al.  Cerebral demyelination associated with disorders of the reticuloendothelial system. , 1959, Lancet.

[459]  E. Mancall,et al.  Progressive multifocal leuko-encephalopathy; a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin's disease. , 1958, Brain : a journal of neurology.

[460]  E. Christensen,et al.  A CASE OF SCHILDER'S DISEASE IN AN ADULT WITH REMARKS TO THE ETIOLOGY AND PATHOGENESIS , 1955, Acta psychiatrica et neurologica Scandinavica.

[461]  S. J. Thannhauser,et al.  HODGKIN'S DISEASE ASSOCIATED WITH SCHILDER'S DISEASE , 1945 .

[462]  N. W. Winkelman,et al.  LYMPHOGRANULOMATOSIS (HODGKIN'S DISEASE) OF THE NERVOUS SYSTEM , 1941 .

[463]  L. Ngo,et al.  JC virus granule cell neuronopathy is associated with VP1 C terminus mutants. , 2012, The Journal of general virology.

[464]  K. Simon,et al.  Multi-site analytical validation of an assay to detect anti-JCV antibodies in human serum and plasma. , 2012, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[465]  R. Frisque,et al.  JC virus T′ proteins encoded by alternatively spliced early mRNAs enhance T antigen-mediated viral DNA replication in human cells , 2011, Journal of NeuroVirology.

[466]  C. Ryschkewitsch,et al.  Predicted amino acid sequences for 100 JCV strains , 2011, Journal of NeuroVirology.

[467]  J. Berger,et al.  The bone marrow, B cells, and JC virus , 2011, Journal of NeuroVirology.

[468]  A. Ropper,et al.  Rearrangement of the JC virus regulatory region sequence in the bone marrow of a patient with rheumatoid arthritis and progressive multifocal leukoencephalopathy , 2011, Journal of NeuroVirology.

[469]  Y. Niv,et al.  Presence of JC Virus DNA in the Tumor Tissue and Normal Mucosa of Patients with Sporadic Colorectal Cancer (CRC) or with Positive Family History and Bethesda Criteria , 2011, Digestive Diseases and Sciences.

[470]  W. Atwood,et al.  Early events in the life cycle of JC virus as potential therapeutic targets for the treatment of progressive multifocal leukoencephalopathy , 2011, Journal of NeuroVirology.

[471]  A. Aksamit.  Treatment of non-AIDS progressive multifocal leukoencephalopathy with cytosine arabinoside , 2011, Journal of NeuroVirology.

[472]  J. Margolick,et al.  John Cunningham Virus Antibody and Viremia as Predictors of Progressive Multifocal Leukoencephalopathy in Human Immunodeficiency Virus-1–Infected Individuals , 2011 .

[473]  N. Letvin,et al.  JCV-specific cellular immune response correlates with a favorable clinical outcome in HIV-infected individuals with progressive multifocal leukoencephalopathy , 2011, Journal of NeuroVirology.

[474]  W. Atwood.  A combination of low-dose chlorpromazine and neutralizing antibodies inhibits the spread of JC virus (JCV) in a tissue culture model: Implications for prophylactic and therapeutic treatment of progressive multifocal leukencephalopathy , 2011, Journal of NeuroVirology.

[475]  A. Nath,et al.  Epidemiological evidence and molecular basis of interactions between HIV and JC virus , 2011, Journal of NeuroVirology.

[476]  G. Fadda,et al.  Characterization of JC virus in cerebrospinal fluid from HIV-1 infected patients with progressive multifocal leukoencephalopathy: insights into viral pathogenesis and disease prognosis , 2011, Journal of NeuroVirology.

[477]  E. Major,et al.  A classification scheme for human polyomavirus JCV variants based on the nucleotide sequence of the noncoding regulatory region , 2011, Journal of NeuroVirology.

[478]  Kozue Tanaka,et al.  Mefloquine treatment in a patient suffering from progressive multifocal leukoencephalopathy after umbilical cord blood transplant. , 2010, Internal medicine.

[479]  Mengding Qian,et al.  Cellular entry of polyomaviruses. , 2010, Current topics in microbiology and immunology.

[480]  R. Lonergan,et al.  Asymptomatic reactivation of JC virus in patients treated with natalizumab. , 2009, The New England journal of medicine.

[481]  S. Toovey.  Mefloquine neurotoxicity: a literature review. , 2009, Travel medicine and infectious disease.

[482]  G. Kronborg,et al.  Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study. , 2009, The Journal of infectious diseases.

[483]  A. Nath,et al.  The absence of JC virus antigens in Indian children with medulloblastomas. , 2009, Indian journal of pathology & microbiology.

[484]  L. Richards,et al.  Nuclear Factor One Transcription Factors in CNS Development , 2008, Molecular Neurobiology.

[485]  M. Yoshino,et al.  JC viral DNA chip allows geographical localization of unidentified cadavers for rapid identification. , 2008, Forensic science international. Genetics.

[486]  M. Sanson,et al.  [Progressive multifocal leukoencephalopathy in a non-AIDS patient: high efficiency of combined cytarabine and cidofovir]. , 2007, La Revue de medecine interne.

[487]  K. Khalili,et al.  A novel role of Rac1 GTPase in JCV T-antigen-mediated beta-catenin stabilization. , 2007, Oncogene.

[488]  E. Major,et al.  JC virus can infect human immune and nervous system progenitor cells: implications for pathogenesis. , 2006, Advances in experimental medicine and biology.

[489]  J. Dillner,et al.  Serological diagnosis of human polyomavirus infection. , 2006, Advances in experimental medicine and biology.

[490]  D. Gilden,et al.  Growth of JC virus in adult human brain cell cultures , 2005, Archives of Virology.

[491]  A. Lukowsky,et al.  Absence of SV40 and other polyomavirus (JCV, BKV) DNA in primary cutaneous B cell lymphomas. , 2005, The Journal of investigative dermatology.

[492]  Eric Lewin Altschuler,et al.  The atypical antipsychotic agents ziprasidone [correction of zisprasidone], risperdone and olanzapine as treatment for and prophylaxis against progressive multifocal leukoencephalopathy. , 2005, Medical hypotheses.

[493]  W. Blattner,et al.  BK virus and a new type of JC virus excreted by HIV-1 positive patients in rural Tanzania , 2005, Archives of Virology.

[494]  T. Lazzarotto,et al.  Human cytomegalovirus replication correlates with differentiation in a hematopoietic progenitor cell line and can be modulated by HIV-1 , 2005, Archives of Virology.

[495]  C. Wiley,et al.  Human immunodeficiency virus (HIV) and JC virus in acquired immune deficiency syndrome (AIDS) patients with progressive multifocal leukoencephalopathy , 2004, Acta Neuropathologica.

[496]  K. Khalili,et al.  Interaction between JCV large T-antigen and beta-catenin. , 2004, Oncogene.

[497]  M. Ilia.  Oct-6 transcription factor. , 2004, International review of neurobiology.

[498]  A. Lazzarin,et al.  Highly active antiretroviral therapy and progressive multifocal leukoencephalopathy: effects on cerebrospinal fluid markers of JC virus replication and immune response. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[499]  P. Cinque,et al.  Analysis of the transcriptional control region in progressive multifocal leukoencephalopathy. , 2000, Journal of neurovirology.

[500]  G L Gallia,et al.  Puralpha: a multifunctional single-stranded DNA- and RNA-binding protein. , 2000, Nucleic acids research.

[501]  G. Gallia,et al.  Association of HIV-1 Tat with the cellular protein, Puralpha, is mediated by RNA. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[502]  G. Gallia,et al.  A 23-bp sequence element from human neurotropic JC virus is responsive to NF-kappa B subunits. , 1999, Virology.

[503]  D. Latchman,et al.  Regulation of DNA virus transcription by cellular POU family transcription factors , 1999, Reviews in medical virology.

[504]  N. White,et al.  Cerebral uptake of mefloquine enantiomers in fatal cerebral malaria. , 1999, International journal of clinical pharmacology and therapeutics.

[505]  E. Goodman,et al.  Successful resolution of progressive multifocal leukoencephalopathy after combination therapy with cidofovir and cytosine arabinoside. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[506]  E. Major,et al.  The efficacy of nucleoside analogs against JC virus multiplication in a persistently infected human fetal brain cell line. , 1998, Journal of neurovirology.

[507]  A. Nakanishi,et al.  How do animal DNA viruses get to the nucleus? , 1998, Annual review of microbiology.

[508]  E. Major,et al.  JC virus infection in cells from lymphoid tissue. , 1998, Developments in biological standardization.

[509]  G. Ault,et al.  Activity of JC virus archetype and PML-type regulatory regions in glial cells. , 1997, The Journal of general virology.

[510]  C. Ryschkewitsch,et al.  Five complete genomes of JC virus Type 3 from Africans and African Americans , 1997, Archives of Virology.

[511]  J. Kartenbeck,et al.  Major histocompatibility complex class I molecules mediate association of SV40 with caveolae. , 1997, Molecular biology of the cell.

[512]  H. Petry,et al.  Efficient production of JC virus in SVG cells and the use of purified viral antigens for analysis of specific humoral and cellular immune response. , 1997, Journal of virological methods.

[513]  R. Frisque,et al.  Identification of three new JC virus proteins generated by alternative splicing of the early viral mRNA. , 1995, Journal of neurovirology.

[514]  S. Günther,et al.  Infection of human polyomaviruses JC and BK in peripheral blood leukocytes from immunocompetent individuals. , 1994, Virology.

[515]  R. Frisque,et al.  Factors contributing to the restricted DNA replicating activity of JC virus. , 1991, Virology.

[516]  M. Hutchinson,et al.  Progressive multifocal leukoencephalopathy-remission with cytarabine. , 1990, The Journal of infection.

[517]  R. Frisque.  Regulatory sequences and virus-cell interactions of JC virus. , 1983, Progress in clinical and biological research.

[518]  E. Major.  JC virus T protein expression in owl monkey tumor cell lines. , 1983, Progress in clinical and biological research.

[519]  K. Shah,et al.  Serologic studies of papovavirus infections in pregnant women and renal transplant recipients. , 1983, Progress in clinical and biological research.

[520]  B. Chronwall,et al.  Glial and divergent cells in primate central nervous system tumors induced by JC virus isolated from human progressive multifocal leukoencephalopathy (PML). , 1983, Progress in clinical and biological research.

[521]  B. Padgett,et al.  The detection of JC viral genome in owl monkey tumors. , 1983, Progress in clinical and biological research.

[522]  P. Mckeever,et al.  Viral-induced astrocytomas in squirrel monkeys. , 1983, Progress in clinical and biological research.

[523]  E. Borden,et al.  Survey of human polyomavirus (JCV, BKV) infections in 139 patients with lung cancer, breast cancer, melanoma, or lymphoma. , 1983, Progress in clinical and biological research.

[524]  R. Traub,et al.  Antibody responses to JC virus-associated antigens by tumor-bearing owl monkeys. , 1983, Progress in clinical and biological research.

[525]  B. Padgett,et al.  The epidemiology of human polyomaviruses. , 1983, Progress in clinical and biological research.

[526]  J. Sever,et al.  New world primates as a model of viral-induced astrocytomas. , 1983, Progress in clinical and biological research.

[527]  J. Sever,et al.  Neuroradiological studies of JCV-induced astrocytomas in nonhuman primates. , 1983, Progress in clinical and biological research.

[528]  B. Padgett,et al.  Virologic and serologic studies of progressive multifocal leukoencephalopathy. , 1983, Progress in clinical and biological research.

[529]  E. Richardson,et al.  Progressive multifocal leukoencephalopathy: its pathological features. , 1983, Progress in clinical and biological research.

[530]  Y. Gluzman,et al.  Identification of a promoter component involved in positioning the 5' termini of simian virus 40 early mRNAs. , 1981, Proceedings of the National Academy of Sciences of the United States of America.